How we take our medications and what happens when it goes horribly wrong
| Dates: | 11 December 2013 |
|---|
| Times: | 13:00 - 14:00 |
|---|
| What is it: | Seminar |
|---|
| Organiser: | Manchester Pharmacy School |
|---|
| Who is it for: | Adults, Alumni, Current University students, University staff |
|---|
| Speaker: | Dr Doug Steinke |
|---|
|
Host: Manchester Pharmacy School
Biography:
Doug Steinke received his pharmacy degree from the University of Manitoba in Canada and practised primarily in community pharmacy in Kingston, Ontario. He received his Masters in Science in Epidemiology and Biostatistics from Queen’s University in Kingston, Ontario. He obtained a Bayer Fellowship for his PhD studies in Pharmacoepidemiology at the University of Dundee, Scotland. He then worked for the Information and Statistics Division of the NHS in Scotland for many years. Wanting to try his hand at academia, he took an Assistant Professor position at the University of Kentucky College of Pharmacy in Lexington Kentucky. He left there in 2011 to take a position at the University of Manchester as Senior Lecturer in Pharmacoepidemiology.
Abstract:
Scientists develop a drug, test its best use and determine the best dose. Doctors make medical decisions on how to best treat diseases and prescribe the medication. Pharmacists tell patients about the best use for the medication and any problems that may occur. Happily, the patient leaves the pharmacy more knowledgeable. Once the patient has the prescription at home, we have lost control how it is going to be taken. Healthcare professionals have no idea what is going to happen next once the patient is back in the community.
However, one way to evaluate medication use is with pharmacoepidemiology. Pharmacoepidemiology is the study of medication use in large populations. This is different to randomised control trails that determine if the drug works (efficacy), as it focuses more on how/where/who/when it works best (effectiveness). Pharmacoepidemiology usually links up the use of a medication and an outcome of interest that could be either bad (adverse drug reaction) or good (prevention of disease). During this seminar I will talk about my research in pharmacoepidemiology and demonstrate some of the highs, interesting points and lows of working with large populations and third party data. The seminar will be interactive and have some hands-on examples of epidemiology of drugs.
Speaker
Dr Doug Steinke
Role: Senior Lecturer in Pharmacoepidemiology
Organisation: University of Manchester
Travel and Contact Information
Find event
Lecture Theatre B
Roscoe Building
Manchester
